{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-030089","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2025-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.866091+00:00","generated_at":"2026-05-23T18:38:23.023495+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TherapeuticsMD files lawsuit against Mayne Pharma for breach of contract over 2022 agreements","bullets":["Filed April 8, 2025 in U.S. District Court for Delaware (Case No. not assigned).","Seeks damages for breach of contract, implied covenant, fraudulent inducement, and unjust enrichment.","Dispute centers on net working capital allowances under License and Transaction Agreements dated December 4, 2022.","No specified damages amount; litigation outcome uncertain."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-030089","json":"https://secwatch.observer/filing/0001213900-25-030089.json","markdown":"https://secwatch.observer/filing/0001213900-25-030089.md","text":"https://secwatch.observer/filing/0001213900-25-030089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000121390025030089/0001213900-25-030089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000121390025030089/ea0237667-8k_therap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:38:23.023495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}